AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/149
RISK-FACTORS IN BONE-MARROW TRANSPLANT RECIPIENTS WITH LEUKEMIA - INCREASED RELAPSE RISK IN PATIENTS TREATED WITH CIPROFLOXACIN FOR GUT DECONTAMINATION
Authors: CARLENS S RINGDEN O ASCHAN J HAGGLUND H LJUNGMAN P MATTSSON J REMBERGER M
Citation: S. Carlens et al., RISK-FACTORS IN BONE-MARROW TRANSPLANT RECIPIENTS WITH LEUKEMIA - INCREASED RELAPSE RISK IN PATIENTS TREATED WITH CIPROFLOXACIN FOR GUT DECONTAMINATION, Clinical transplantation, 12(2), 1998, pp. 84-92
RISK-FACTORS FOR CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION - A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Authors: CARLENS S RINGDEN O REMBERGER M LONNQVIST B HAGGLUND H KLAESSON S MATTSSON J SVAHN BM WINIARSKI J LJUNGMAN P ASCHAN J
Citation: S. Carlens et al., RISK-FACTORS FOR CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION - A RETROSPECTIVE SINGLE-CENTER ANALYSIS, Bone marrow transplantation, 22(8), 1998, pp. 755-761
BACTEREMIA DURING THE APLASTIC PHASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IS ASSOCIATED WITH EARLY DEATH FROM INVASIVE FUNGAL INFECTION
Authors: SPARRELID E HAGGLUND H REMBERGER M RINGDEN O LONNQVIST B LJUNGMAN P ANDERSSON J
Citation: E. Sparrelid et al., BACTEREMIA DURING THE APLASTIC PHASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IS ASSOCIATED WITH EARLY DEATH FROM INVASIVE FUNGAL INFECTION, Bone marrow transplantation, 22(8), 1998, pp. 795-800
SEVERE AND COMMON SIDE-EFFECTS OF AMPHOTERICIN-B LIPID COMPLEX (ABELCET)
Authors: RINGDEN O JONSSON V HANSEN M TOLLEMAR J JACOBSEN N
Citation: O. Ringden et al., SEVERE AND COMMON SIDE-EFFECTS OF AMPHOTERICIN-B LIPID COMPLEX (ABELCET), Bone marrow transplantation, 22(7), 1998, pp. 733-734
DETECTION OF HEPATITIS-G VIRUS GB-VIRUS-C AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: LJUNGMAN P HALASZ R HAGGLUND H SONNERBORG A RINGDEN O
Citation: P. Ljungman et al., DETECTION OF HEPATITIS-G VIRUS GB-VIRUS-C AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 22(5), 1998, pp. 499-501
FASTER NEUTROPHIL AND PLATELET ENGRAFTMENT, BUT NO DIFFERENCES IN ACUTE GVHD OR SURVIVAL, USING PERIPHERAL-BLOOD STEM-CELLS FROM RELATED AND UNRELATED DONORS, COMPARED TO BONE-MARROW
Authors: HAGGLUND H RINGDEN O REMBERGER M LONNQVIST B SPARRELID E TAMMIK L KUMLIEN G
Citation: H. Hagglund et al., FASTER NEUTROPHIL AND PLATELET ENGRAFTMENT, BUT NO DIFFERENCES IN ACUTE GVHD OR SURVIVAL, USING PERIPHERAL-BLOOD STEM-CELLS FROM RELATED AND UNRELATED DONORS, COMPARED TO BONE-MARROW, Bone marrow transplantation, 22(2), 1998, pp. 131-136
BOOSTER MARROW OR BLOOD-CELLS FOR GRAFT FAILURE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: REMBERGER M RINGDEN O LJUNGMAN P HAGGLUND H WINIARSKI J LONNQVIST B ASCHAN J
Citation: M. Remberger et al., BOOSTER MARROW OR BLOOD-CELLS FOR GRAFT FAILURE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 22(1), 1998, pp. 73-78
INTRAOSSEOUS COMPARED TO INTRAVENOUS-INFUSION OF ALLOGENEIC BONE-MARROW
Authors: HAGGLUND H RINGDEN O AGREN B WENNBERG L REMBERGER M RUNDQUIST L SVAHN BM ASPELIN P
Citation: H. Hagglund et al., INTRAOSSEOUS COMPARED TO INTRAVENOUS-INFUSION OF ALLOGENEIC BONE-MARROW, Bone marrow transplantation, 21(4), 1998, pp. 331-335
OUTCOME OF ALLOGENEIC PBPC COMPARED TO BONE-MARROW FROM RELATED AND UNRELATED DONORS
Authors: HAGGLUND H RINGDEN O LONNQVIST B SPARRELID E REMBERGER M KUMLIEN G
Citation: H. Hagglund et al., OUTCOME OF ALLOGENEIC PBPC COMPARED TO BONE-MARROW FROM RELATED AND UNRELATED DONORS, Bone marrow transplantation, 21, 1998, pp. 42-42
FASTER ENGRAFTMENT OF PERIPHERAL-BLOOD PROGENITOR CELLS COMPARED TO BONE-MARROW FROM UNRELATED DONORS
Authors: RINGDEN O HAGGLUND H RUNDE V BASU O KROSCHINSKY F STOCKSCHLADER M POTTER MN
Citation: O. Ringden et al., FASTER ENGRAFTMENT OF PERIPHERAL-BLOOD PROGENITOR CELLS COMPARED TO BONE-MARROW FROM UNRELATED DONORS, Bone marrow transplantation, 21, 1998, pp. 81-84
ALLOGENEIC BONE-MARROW TRANSPLANTATION VS FILGRASTIM-MOBILIZED PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN PATIENTS WITH EARLY LEUKEMIA - FIRST RESULTS OF A RANDOMIZED MULTICENTER TRIAL OF THE EUROPEANGROUP FOR BLOOD AND MARROW TRANSPLANTATION
Authors: SCHMITZ N BACIGALUPO A HASENCLEVER D NAGLER A GLUCKMAN E CLARK P BOURQUELOT P GREINIX H FRICKHOFEN N RINGDEN O ZANDER A APPERLEY JF GORIN C BORKETT K SCHWAB G GOEBEL M RUSSELL NH GRATWOHL A
Citation: N. Schmitz et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION VS FILGRASTIM-MOBILIZED PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN PATIENTS WITH EARLY LEUKEMIA - FIRST RESULTS OF A RANDOMIZED MULTICENTER TRIAL OF THE EUROPEANGROUP FOR BLOOD AND MARROW TRANSPLANTATION, Bone marrow transplantation, 21(10), 1998, pp. 995-1003
TRANSPLANTATION WITH UNRELATED BONE-MARROW IN LEUKEMIC PATIENTS ABOVE40 YEARS OF AGE
Authors: RINGDEN O REMBERGER M MATTSSON J ASCHAN J CARLENS S HAGGLUND H LONNQVIST B SPARRELID E LJUNGMAN P
Citation: O. Ringden et al., TRANSPLANTATION WITH UNRELATED BONE-MARROW IN LEUKEMIC PATIENTS ABOVE40 YEARS OF AGE, Bone marrow transplantation, 21(1), 1998, pp. 43-49
CADAVERIC BONE-MARROW AND SPLEEN-CELLS FOR TRANSPLANTATION
Authors: SODERDAHL G TAMMIK C REMBERGER M RINGDEN O
Citation: G. Soderdahl et al., CADAVERIC BONE-MARROW AND SPLEEN-CELLS FOR TRANSPLANTATION, Bone marrow transplantation, 21(1), 1998, pp. 79-84
RESULTS OF BONE-MARROW TRANSPLANTATION IN PH-A, HLA-B AND HLA-DR IDENTICAL DONORS( ALL USING RELATED OR UNRELATED HLA)
Authors: LARSSON K WINIARSKI J LONNQVIST B RINGDEN O LJUNGMAN P
Citation: K. Larsson et al., RESULTS OF BONE-MARROW TRANSPLANTATION IN PH-A, HLA-B AND HLA-DR IDENTICAL DONORS( ALL USING RELATED OR UNRELATED HLA), Bone marrow transplantation, 21, 1998, pp. 6-6
ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH ACUTE-LEUKEMIA WHO HAD A RELAPSE AFTER AN AUTOGRAFT
Authors: RINGDEN O LABOPIN M FRASSONI F GORIN NC
Citation: O. Ringden et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH ACUTE-LEUKEMIA WHO HAD A RELAPSE AFTER AN AUTOGRAFT, Bone marrow transplantation, 21, 1998, pp. 15-15
A PROSPECTIVE RANDOMIZED TRIAL GIVING G-CSF AT DIFFERENT TIMES AFTER UNRELATED BMT
Authors: HAGGLUND H RINGDEN O OHMAN S REMBERGER M CARLENS S MATTSSON J
Citation: H. Hagglund et al., A PROSPECTIVE RANDOMIZED TRIAL GIVING G-CSF AT DIFFERENT TIMES AFTER UNRELATED BMT, Bone marrow transplantation, 21, 1998, pp. 113-113
LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, USING UNRELATED HLA-A, HLA-B, AND HLA-DR IDENTICAL DONORS AND CONDITIONING, INCLUDING ANTI-T-CELL ANTIBODIES
Authors: RINGDEN O REMBERGER M CARLENS S HAGGLUND H MATTSSON J ASCHAN J LONNQVIST B KLAESSON S WINIARSKI J DALIANIS T OLERUP O SPARRELID E LJUNGMAN P
Citation: O. Ringden et al., LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, USING UNRELATED HLA-A, HLA-B, AND HLA-DR IDENTICAL DONORS AND CONDITIONING, INCLUDING ANTI-T-CELL ANTIBODIES, Bone marrow transplantation, 21, 1998, pp. 114-114
FASTER NEUTROPHIL AND PLATELET ENGRAFTMENT, BUT NO INCREASE IN ACUTE GVHD, USING PERIPHERAL-BLOOD STEM-CELLS FROM RELATED AND UNRELATED DONORS, COMPARED TO BONE-MARROW
Authors: HAGGLUND H RINGDEN O REMBERGER M LONNQVIST B SPARRELID E TAMMIK L KUMLIEN G
Citation: H. Hagglund et al., FASTER NEUTROPHIL AND PLATELET ENGRAFTMENT, BUT NO INCREASE IN ACUTE GVHD, USING PERIPHERAL-BLOOD STEM-CELLS FROM RELATED AND UNRELATED DONORS, COMPARED TO BONE-MARROW, Bone marrow transplantation, 21, 1998, pp. 143-143
BILATERAL SUBDURAL HEMATOMAS FOLLOWING INTRATHECAL INJECTION IN 3 BONE-MARROW TRANSPLANT RECIPIENTS
Authors: HENTSCHKE P HAGGLUND H MATTSSON J CARLENS S LONNQVIST B LJUNGMAN P ASCHAN J RINGDEN O
Citation: P. Hentschke et al., BILATERAL SUBDURAL HEMATOMAS FOLLOWING INTRATHECAL INJECTION IN 3 BONE-MARROW TRANSPLANT RECIPIENTS, Bone marrow transplantation, 21, 1998, pp. 326-326
IMMUNOSUPPRESSIVE EFFECTS OF RAPAMYCIN
Authors: REMBERGER M TAMMIK L RINGDEN O
Citation: M. Remberger et al., IMMUNOSUPPRESSIVE EFFECTS OF RAPAMYCIN, Bone marrow transplantation, 21, 1998, pp. 366-366
PUVA TREATMENT FOR GRAFT-VERSUS-HOST DISEASE - A RETROSPECTIVE ANALYSIS
Authors: ASCHAN J EMTESTAM L LJUNGMAN P LONNQVIST B RINGDEN O
Citation: J. Aschan et al., PUVA TREATMENT FOR GRAFT-VERSUS-HOST DISEASE - A RETROSPECTIVE ANALYSIS, Bone marrow transplantation, 21, 1998, pp. 395-395
LOW-DOSE CYCLOSPORINE PROPHYLAXIS DOES NOT INCREASE THE RISK OF SEVERE ACUTE GVHD IN HLA-IDENTICAL SIBLING MARROW TRANSPLANT RECIPIENTS WITH LEUKEMIA
Authors: CARLENS S ASCHAN J REMBERGER M RINGDEN O
Citation: S. Carlens et al., LOW-DOSE CYCLOSPORINE PROPHYLAXIS DOES NOT INCREASE THE RISK OF SEVERE ACUTE GVHD IN HLA-IDENTICAL SIBLING MARROW TRANSPLANT RECIPIENTS WITH LEUKEMIA, Bone marrow transplantation, 21, 1998, pp. 414-414
CLINICAL EFFECTS OF INTRAVENOUS IMMUNE GLOBULIN TREATMENT AFTER BONE-MARROW TRANSPLANTATION, USING HLA MATCHED UNRELATED DONORS
Authors: KLAESSON S HAGGLUND H LJUNGMAN P CARLENS S MATTSSON J REMBERGER M SPARRELID E WINIARSKI J RINGDEN O
Citation: S. Klaesson et al., CLINICAL EFFECTS OF INTRAVENOUS IMMUNE GLOBULIN TREATMENT AFTER BONE-MARROW TRANSPLANTATION, USING HLA MATCHED UNRELATED DONORS, Bone marrow transplantation, 21, 1998, pp. 415-415
DETECTION OF HEPATITIS-G VIRUS (HGV) AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
Authors: LJUNGMAN P HALASZ R HAGGLUND H SONNERBORG A RINGDEN O
Citation: P. Ljungman et al., DETECTION OF HEPATITIS-G VIRUS (HGV) AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Bone marrow transplantation, 21, 1998, pp. 526-526
ENGRAFTMENT AND CHIMERISM, PARTICULARLY OF T-CELLS AND B-CELLS, IN CHILDREN UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: WINIARSKI J GUSTAFSSON A BORGSTROM B MATTSON J WESTER D RINGDEN O LJUNGMAN P DALIANIS T
Citation: J. Winiarski et al., ENGRAFTMENT AND CHIMERISM, PARTICULARLY OF T-CELLS AND B-CELLS, IN CHILDREN UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 632-632
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>